MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
Condition: Relapsing-remitting Multiple Sclerosis (RRMS)Interventions: Drug: fingolimod; Drug: copaxoneSponsors: Novartis Pharmaceuticals; NovartisRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2012 Category: Research Source Type: clinical trials
MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
Condition: Relapsing-remitting Multiple Sclerosis (RRMS)Interventions: Drug: fingolimod; Drug: copaxoneSponsor: Novartis PharmaceuticalsRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2012 Category: Research Source Type: clinical trials
MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
Condition: Relapsing-remitting Multiple Sclerosis (RRMS)Interventions: Drug: fingolimod; Drug: copaxoneSponsor: Novartis PharmaceuticalsRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2012 Category: Research Source Type: clinical trials
MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
Condition: Relapsing-remitting Multiple Sclerosis (RRMS)Interventions: Drug: fingolimod; Drug: copaxoneSponsor: Novartis PharmaceuticalsRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2012 Category: Research Source Type: clinical trials
MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
Condition: Relapsing-remitting Multiple Sclerosis (RRMS)Interventions: Drug: fingolimod; Drug: copaxoneSponsor: Novartis PharmaceuticalsRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2012 Category: Research Source Type: clinical trials
MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
Condition: Relapsing-remitting Multiple Sclerosis (RRMS)Interventions: Drug: fingolimod; Drug: copaxoneSponsor: Novartis PharmaceuticalsRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2012 Category: Research Source Type: clinical trials
MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
Condition: Relapsing-remitting Multiple Sclerosis (RRMS)Interventions: Drug: fingolimod; Drug: copaxoneSponsor: Novartis PharmaceuticalsRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2012 Category: Research Source Type: clinical trials
Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate
Condition: Multiple SclerosisInterventions: Drug: diclofenac sodium topical gel; Other: PlaceboSponsors: Brown, Theodore R., M.D., MPH; Teva Neuroscience, Inc.Completed - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2011 Category: Research Source Type: clinical trials
